comparemela.com

Latest Breaking News On - Novartis gene therapies - Page 3 : comparemela.com

AC Immune SA Appoints New Chief Medical Officer

AC Immune SA Appoints New Chief Medical Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
Switzerland
Portugal
Lisbon
Lisboa
Germany
America
Gary-waanders
Johannes-streffer
Eli-lilly
Nuno-mendon
Andrea-pfeifer

Cour Pharmaceuticals Appoints Dannielle Appelhans As Chief Operating Officer

Cour Pharmaceuticals Appoints Dannielle Appelhans As Chief Operating Officer
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Chicago
Illinois
United-states
Northwestern-university
Michigan
Dannielle-appelhans
Brianc-bock
Johnj-puisis
Eli-lilly
Novartis
Massachusetts-institute-of-technology-school-engineering
Rubius-therapeutics-inc

Novartis Bolsters Neuro Pipeline, RNA Capabilities with Up-to-$1B DTx Pharma Acquisition

Novartis Bolsters Neuro Pipeline, RNA Capabilities with Up-to-$1B DTx Pharma Acquisition
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United-states
Switzerland
Cambridge
Cambridgeshire
United-kingdom
San-diego
California
Swiss
Roberth-baloh
Los-angeles
Dtx-pharma
Artie-suckow

Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned Researchers Drs. Christine Seidman and Alex Marson. | May 10, 2023

United-states
American
Wendy-ryan
Mark-angelino
Christine-seidman
Angela-thedinga
Christine-edry-seidman
Faraz-ali
Alexander-marson
Guangping-gao
Research-development-rd-expenses
Globenewswire-inc

vimarsana © 2020. All Rights Reserved.